This site is intended for healthcare professionals only
LoginRegister
USFDA nod to JnJ Tremfya for Crohns diseaseJ&J agrees to retain all talc related liabilities from litigation in US, Canada
Eli Lilly raises annual profit forecast on strength of diabetes drugEli Lilly raises annual profit forecast on strength of diabetes drug
Giovanni Caforio to retire as Bristol Myers Squibb CEOGiovanni Caforio to retire as Bristol Myers Squibb CEO
USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers SquibbBristol Myers Squibb gets positive CHMP opinion recommending nod for CAMZYOS for treatment of...
AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitorAstraZeneca beat expectations for first-quarter profit, revenue
Novartis opens new radioligand therapy manufacturing facility in CaliforniaNovartis gets positive CHMP opinion for Cosentyx in adults with hidradenitis suppurativa
NPPA Fixes Retail Prices for 28 Drug Formulations Including Dapagliflozin, Telmisartan, Amoxycillin, DetailsNPPA Fixes Ceiling Prices for 8 IV Fluids with packages having special features
USFDA nod to JnJ Tremfya for Crohns diseaseSubmit Additional Safty Data: CDSCO Tells J&J on Ustekinumab solution for injection
GSK gets positive EMA panel opinion for Respiratory syncytial virus older adult vaccineGSK gets positive EMA panel opinion for Respiratory syncytial virus older adult vaccine
USFDA panel backs restricted use of AstraZeneca Prostrate cancer drugUSFDA panel backs restricted use of AstraZeneca Prostrate cancer drug
Biocon unveils Liraglutide for diabetes, obesity in NetherlandsBiocon Biologics Bengaluru facility gets EU GMP certification for Bevacizumab
NPPA Fixes Ceiling Price of ringer lactate injectionNPPA Fixes Ceiling Price of ringer lactate injection
X